Article
In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA.
Antiviral therapy - 1 Jan 1999
Wainberg M A, Miller M D, Quan Y, Salomon H, Mulato A S, Lamy P D, Margot N A, Anton K E, Cherrington J M
Abstract excerpt
9-(2-phosphonomethoxypropyl)adenine (PMPA) has demonstrated remarkable anti-simian immunodeficiency virus (SIV) activity in macaque models of SIV infection and transmission prevention. Recently, PMPA and its oral prodrug, bis-POC PMPA, have also shown potent anti-human immunodeficiency virus type 1 (HIV-1) activity in Phase I clinical studies. In vitro experiments were performed to address the resistance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
